Hikma Pharmaceutical | HIK - Ebit

Precio De Mercado
1,465.00
Cambio Diario
-2.00 -0.14%
Mensual
4.46%
Anual
-29.43%
Q2 Expectativa
1,414.37




Ebit Cambio Fecha
Almirall EUR 30.23M 12.8M 2025-12
argenx SE USD 394M 22.86M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Autolus Therapeutics Ltd USD -59.51M 12.95M 2026-03
Bayer EUR 3.53B 2.42B 2026-03
Fresenius EUR 713M 139M 2025-12
Genmab DKK 260M 199M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
GRIFOLS EUR 249M 103.11M 2026-03
Hikma Pharmaceutical USD 348M 31M 2025-12
Lakefront Biotherapeutics EUR -63.7M 844.26M 2026-03
Lonza CHF 673M 54M 2025-06
Merck EUR 1.05B 572M 2026-03
Orion EUR 114.8M 213.3M 2026-03
Recordati EUR 231.11M 47.11M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.94B 239M 2026-03
UCB EUR 1.29B 571M 2025-12